ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2013

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

23,937Medicare Part D Prescriptions Filled, Including Refills

Rank: 21 out of 343

$1.06M Total Retail Price of All Prescriptions

Rank: 38 out of 343

581 Patients Receiving at Least One Drug in Part D
68% Patients 65 Years and Older
89% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg 81928cdb0ebe162ff75cf405bfacadd396bf3ec84bc467b6f3e612dd63daa776 Average for
this specialty
in Mississippi
Lower avg 72b1978e1dcc0b845f89d17d692cfff7aeaf8d8bce70310d8bfc535db2daf62a

Schedule Two
Controlled Substances

13% of this provider’s 581 patients filled at least one prescription for a schedule two drug, compared to an average of 3%.

Schedule Three
Controlled Substances

29% of this provider’s 581 patients filled at least one prescription for a schedule three drug, compared to an average of 16%.

Brand Name Drugs

28% of this provider’s prescriptions were for brand-name drugs, compared to an average of 22%.

Prescription Price

$44 was the average price of a prescription from this provider, compared to $53 among peers.

Prescriptions per Patient

41 is the average number of prescriptions (including refills) per patient, compared to an average of 24.


This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

B

A benzodiazepine, or tranquilizer. More » The American Geriatrics Society says these drugs increase the risk of cognitive impairment, delirium, falls and fractures in older adults.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled with Refills Prescriptions
to 65+
Patients Recieving this Drug Category For this Prescriber For All Prescribers in
This Specialty in Mississippi
AMLODIPINE BESYLATE 853 710 83 1 1
OMEPRAZOLE 790 555 114 2 3
SIMVASTATIN 787 443 101 3 7
LEVOTHYROXINE SODIUM 786 464 93 4 5
SERTRALINE HCL 763 725 57 5 33
HYDROCODONE-ACETAMINOPHEN 604 531 169 S3 6 2
POTASSIUM CHLORIDE 471 422 75 7 10
GABAPENTIN 463 394 60 8 12
METOPROLOL TARTRATE 445 378 64 9 17
FUROSEMIDE 432 410 73 10 4
LISINOPRIL 419 374 57 11 6
CYMBALTA 403 379 25 12 44
ATORVASTATIN CALCIUM 381 231 50 13 8
WARFARIN SODIUM 367 362* 22 14 18
MIRTAZAPINE 357 345 55 15 68
CARVEDILOL 345 331 46 16 13
TRAZODONE HCL 335 315 57 17 45
BUMETANIDE 311 298 52 18 118
CLOPIDOGREL 307 307 46 19 15
DONEPEZIL HCL 297 279 44 20 28
TAMSULOSIN HCL 296 241 41 21 37
LORAZEPAM 282 257 51 B 22 51
NAMENDA 256 239 15 23 34
FENTANYL 223 199 30 S2 24 119
RANITIDINE HCL 212 192 31 25 38
NOVOLOG 202 197* 39 26 160
MELOXICAM 201 182 40 27 21
NEXIUM 199 182 13 28 26
HYDRALAZINE HCL 178 165 29 29 49
CITALOPRAM HBR 174 157 25 30 23
ZETIA 174 133 13 30 71
PANTOPRAZOLE SODIUM 168 163* 28 32 32
LANTUS 168 163* 37 32 69
METFORMIN HCL 165 138 29 34 9
ISOSORBIDE MONONITRATE ER 164 164 23 35 54
LYRICA 160 155* 13 36 61
FAMOTIDINE* 160 103 22 36 72
POLYETHYLENE GLYCOL 3350 159 132 43 38 74
DIOVAN 152 129 14 39 35
ESCITALOPRAM OXALATE 140 128 23 40 46
LEVETIRACETAM 138 113 19 41 111
PRADAXA 133 128* 12 42 205
ALENDRONATE SODIUM 132 66 15 43 63
SULFAMETHOXAZOLE-TRIMETHOPRIM 131 116 70 44 92
NOVOLOG FLEXPEN 129 124* 23 45 217
LOVASTATIN 127 44 13 46 41
ATENOLOL 125 77 12 47 30
JANTOVEN 123 118* 15 48 143
OXYBUTYNIN CHLORIDE 123 90 16 48 153
HYDROCHLOROTHIAZIDE 121 70 15 50 14
LEVOFLOXACIN 119 114* 74 51 80
CARBIDOPA-LEVODOPA 118 113* 18 52 163
TRIAMTERENE-HCTZ 118 <11 <11 52 39
MEGESTROL ACETATE 114 109* 39 R 54 122
DETROL LA 108 96 13 55 149
ABILIFY 106 101* 11 A 56 135
LOSARTAN POTASSIUM 105 88 14 57 19
CLONIDINE HCL 104 99* 29 58 36
BUSPIRONE HCL 103 71 16 59 117
AVODART 103 <11 <11 59 171
NITROFURANTOIN MONO-MACRO 101 96* 46 61 248
LEVEMIR FLEXPEN 98 98 18 62 125
VESICARE 97 <11 <11 63 146
RISPERIDONE 90 90 15 A 64 97
JANUVIA 89 <11 <11 65 62
LEVEMIR 86 81* 14 66 140
AMIODARONE HCL 85 85 16 67 113
PREDNISONE 84 68 33 68 53
QUETIAPINE FUMARATE 84 72 16 A 68 76
ALPRAZOLAM 82 77* 19 B 70 20
LACTULOSE 82 46 26 70 151
SUCRALFATE 81 <11 <11 72 177
DIVALPROEX SODIUM 78 <11 <11 73 128
CLONAZEPAM 78 57 14 B 73 48
MONTELUKAST SODIUM 77 <11 <11 75 43
SANTYL 74 74 28 76 284
ENOXAPARIN SODIUM 74 69* 29 76 354
HUMALOG 73 68* 13 78 178
ROPINIROLE HCL 71 <11 <11 79 95
PAROXETINE HCL 70 <11 <11 80 73
CRESTOR 69 <11 <11 81 29
DILTIAZEM HCL 69 58 12 81 228
GLIPIZIDE XL 69 <11 <11 81 166
PROMETHAZINE HCL 68 57 31 R 84 108
ALLOPURINOL 68 <11 <11 84 31
LATANOPROST 68 <11 <11 84 240
TIZANIDINE HCL 67 <11 <11 87 77
NYSTATIN 66 66 33 88 198
METOCLOPRAMIDE HCL 65 42 13 89 126
FLUOXETINE HCL 64 <11 <11 90 81
PRAVASTATIN SODIUM 63 35 11 91 11
ZOLPIDEM TARTRATE 62 57* 15 92 24
FENOFIBRATE* 62 <11 <11 92 66
PRIMIDONE 62 <11 <11 92 213
RAMIPRIL 61 44 11 95 89
BUPROPION HCL 58 53* 12 96 330
RANEXA 57 <11 <11 97 250
SPIRIVA 56 56 13 98 87
MISOPROSTOL 55 <11 <11 99 308
METOPROLOL SUCCINATE 55 <11 <11 99 16
CIPROFLOXACIN HCL 55 50* 42 99 57
TOLTERODINE TARTRATE 54 <11 <11 102 386
FLUTICASONE PROPIONATE 53 28 17 103 47
VENLAFAXINE HCL 53 <11 <11 103 254
ADVAIR DISKUS 53 48* 13 103 85
DIGOX 51 51 12 106 86
AZITHROMYCIN 51 32 39 106 65
IPRATROPIUM-ALBUTEROL 50 45* 24 108 257
ALBUTEROL SULFATE 50 45* 36 108 218
LOVAZA 50 <11 <11 108 157
About This Data

Prescribing data from Medicare’s prescription drug benefit, known as Part D, was compiled and released by the Centers for Medicare and Medicaid Services, the federal agency that oversees the program. ProPublica combined that data with additional information released by CMS. The data for 2013 includes nearly 1.4 billion prescriptions written by 1.3 million doctors, nurses and other providers. This database lists about 410,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths of these prescriptions went to patients 65 and older; the rest were for disabled patients Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to checkup@propublica.org and we will update your information. If you have other questions about this data, send a note to checkup@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Dec. 17, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.